Nizam's Institute of Medical Sciences, Hyderabad, India   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Hyderabad Telangana India (1961)

Organization Overview

First Clinical Trial
2004
NCT00643045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Nizam's Institute of Medicai Sciences | Nizam's Institute of Medical Sciences | Nizam's Institute of Medical Sciences Hyderabad | Nizams Institute of Medical Sciences, Hyderabad | NIZAM'S INSTITUTE OF MEDICAL SCIENCES, PANJAGUTTA, HYDERABAD, INDIA | Nizam's Institute of Medical Sciences University, India

Active Ingredients

Drugs in Phase 4 Trials (1)

fish oil (Omegavan) (2 trials)

Drugs in Phase 3 Trials (2)

imidazoquinoline (1 trial)

safinamide (xadago) (2 trials)

Drugs in Phase 2 Trials (1)

Covaxin (1 trial)

Drugs in Phase 1 Trials (1)

riviciclib (2 trials)

Drugs in Other Trials (1)

hydroxyethyl starch (voluven) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Inflammation (Phase 4)

Neoplasms (Phase 1)

Parkinson Disease (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 6